It is well known that pyrimidine derivatives are of great biological interest, especially as antimicrobial, antiviral, anti-inflammatory and antitumor agents (1-7). Some series of pyrimido [4,5-d]pyrimidine-2,5-dione derivatives show antimicrobial activity against Staphylococcus aureus, Bacillus subtilis, Escherichia coli and antifungal activity against Candida albicans and Aspergillus niger, as proved by Sharma et al. (8). Bacimethrin (5-hydroxymethyl-2-methoxy-pyrimidin-4-amine) is a pyrimidine antibiotic active against several staphylococcal infections (9). 2-Thiouracils and 6-aryl-2-thiouracils are well known for their antifungal, antibacterial, anticancer and antiviral activity (10-12). The aim of this study was to synthesize new 6-aryl-5-cyano-2-thiouracil derivatives and to investigate their antimicrobial activity. A series of 6-aryl-5-cyano-2-thiouracil derivatives (1a-d) was synthesized by the reaction of ethyl cyanoacetate with thiourea and aldehydes. These products were used as intermediate compounds for the synthesis of a number of thiouracil derivatives (2a-d to 10a-d). All compounds were screened for antibacterial and antifungal activities. Some of the prepared compounds, 6-(4-fluorophenyl)-4--oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide (2a), 4-oxo-2-thioxo-6-(3,4,5-trimethoxyphenyl)-1,2,3,4--tetrahydropyrimidine-5-carboxamide (2d), 6-(4-fluorophenyl)-4-hydrazino-2-thioxo-1,2-dihydropyrimidine-5-cabonitrile (7a) and 4-hydrazino-2-thioxo-6-(3,4,5-trimethoxyphenyl)-1,2-dihydropyrimidine-5-carbonitrile (7d) revealed promising antimicrobial activity.
Physicochemical and spectral data for the synthesized compounds are given in Tables I and II. Target compounds were synthesized as outlined in Scheme 1. mol)] in 50 mL sodium ethoxide (2.3 g, 0.1 mol) was stirred for 24 h at room temperature and poured onto ice-water, acidified with dil. HCl to give precipitates, which were filtered, dried and recrystallized from DMF/water to give compounds 1a-d, respectively. Aryl-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamides (2a-d) . _ The appropriate thiouracil derivative, 1a (2.47 g, 0.01 mol), 1b (2.72 g, 0.01 mol), 1c (3.08 g, 0.01  mol) or 1d (3.19 g, 0. 01 mol) in conc. sulphuric acid (40 mL), was refluxed for 3 h, cooled, poured onto ice-water and neutralized with ammonia to give compounds 2a-d, respectively, in the form of precipitates, which were filtered, dried and recrystallized from DMF/ water.
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6-Aryl-4-chloro-2-thioxo-1,2-dihydropyrimidine-5-carbonitriles (3a-d).
_ The appropriate thiouracil derivative, 1a (2.47 g, 0.01 mol), 1b (2.72 g, 0.01 mol), 1c (3.08 g, 0.01 mol) or 1d (3.19 g, 0.01 mol), was heated under reflux in phosphorus oxychloride (25 mL) and phosphorus pentachloride (2 g, 0.01 mol) for 8 h, cooled and poured onto ice to precipitate compounds 3a-d, which were washed with petroleum ether, filtered off and dried under vacuum.
3-Aryl-10-oxo-1-thioxo-2,10-dihydro-1H-pyrimido[6,1-b]quinazoline-4-carbonitriles (4a-d).
_ A mixture of the appropriate thiouracil, 3a (2.65 g, 0.01 mol), 3b (2.90 g, 0.01 mol), 3c (3.26 g, 0.01 mol) or 3d (3.37 g, 0.01 mol), and anthranilic acid (1.37 g, 0.01 mol) was refluxed in butanol (50 mL) for 10-12 h, cooled, filtered, dried and recrystallized from DMF/water to give compounds 4a-d, respectively.
7-Aryl-3-oxo-5-thioxo-2,3,5,6-tetrahydroimidazo[1,2-c]pyrimidine-8-carbonitriles (5a-d). -
A mixture of the appropriate thiouracil, 3a (2.65 g, 0.01 mol), 3b (2.90 g, 0.01 mol), 3c (3.26 g, 0.01 mol) or 3d (3.37 g, 0.01 mol) and glycine (0.75 g, 0.01 mol), was refluxed in butanol (30 mL) for 6-9 h, cooled and the separated solid was refluxed with acetic anhydride (10 mL) for 3 h, cooled, filtered, dried and recrystallized from DMF/water to yield compounds 5a-d, respectively.
7-Aryl-5-thioxo-5,6-dihydrotetrazolo[1,5-c]pyrimidine-8-carbonitriles (6a-d)
. _ A mixture of the appropriate thiouracil, 3a (2.65 g, 0.01 mol), 3b (2.90 g, 0.01 mol), 3c (3.26 g, 0.01 mol) or 3d (3.37 g, 0.01 mol) and sodium azide (0.65 g, 0.01 mol), was refluxed in glacial acetic acid (30 mL) for 5-8 h, cooled and the solid was filtered, dried and recrystallized from DMF/water to give compounds 6a-d, respectively.
6-Aryl-4-hydrazino-2-thioxo-1,2-dihydropyrimidine-5-carbonitriles (7a-d).
_ A mixture of the appropriate thiouracil, 3a (2.65 g, 0.01 mol), 3b (2.90 g, 0.01 mol), 3c (3.26 g, 0.01 mol) or 3d (3.37 g, 0.01 mol) and hydrazine hydrate (20 mL, 99 %), was refluxed in methanol (30 mL) for 20 min, cooled, stirred for 24 h and poured onto ice-water. The solid obtained was filtered, dried and recrystallized from DMF/water to yield compounds 7a-d, respectively.
4-(p-Acetyl-phenylamino)-6-aryl-2-thioxo-1,2-dihydropyrimidine-5-carbonitrile (8a-d)
. _ A mixture of the appropriate thiouracil, 3a (1.32 g, 0.05 mol), 3b (1.45 g, 0.05 mol), 3c (1.36 g, 0.05 mol) or 3d (1.68 g, 0.05 mol) and p-aminoacetophenone (0.67 g, 0.05 mol), was refluxed in 25 mL anhydrous pyridine for 10 h, cooled, poured onto ice-HCl, filtered, dried and recrystallized from ethyl acetate to give compounds 8a-d, respectively. (10 a-d) . General procedure. _ A mixture of the appropriate thiouracil, 3a (1.325 g, 0.05 mol), 3b (1.45 g, 0.05 mol), 3c (1.36 g, 0.05 mol) or 3d (1.68 g, 0. 05 mol) and 4-amino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one (4-aminoantipyrine) (1 g, 0.05 mol) or anthranilic acid (0.68 g, 0.05 mol), was refluxed in 25 mL methanol containing 1 mL anhydrous pyridine for 12 h, cooled, poured onto ice-HCl, filtered, dried and recrystallized from DMF/water to give 9a-d or 10a-d, respectively.
4-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-ylamino)-6-aryl-2-thioxo-1,2--dihydropyrimidine-5-carbonitrile (9a-d) and 2-[5-cyano-6-aryl-2-thioxo-1,2-dihydropyrimidine--4-yl-amino]-benzoic acid
Antimicrobial activity
All compounds were evaluated for antibacterial activity against Bacillus subtilis (ATCC 6051), Staphylococcus aureus (ATCC 12600) (Gram-positive), Escherichia coli (ATCC 11775) (Gram-negative) and Candida albicans (ATCC 26555) and Aspergillus flavus (ATCC--11495) (fungi) microorganisms using the disc diffusion method. Disc diffusion sensitivity test was done in the manner identical to that of Bauer et al. (14) . All microorganisms used were obtained from the culture collection of the Department of Microbiology, Microanalytical Centre, Faculty of Science, Cairo University, Cairo, Egypt.
Media for disc sensitivity tests were nutrient agar and Müller-Hinton agar (MHA) purchased from Difco (USA). Non-sterile powder of tested compounds and penicillin and nystatin standards were dissolved in sterile DMSO to yield 2.0 mg mL -1 solution, and passed through a 0.2-mm membrane filter (Millipore Corp, USA). Penicillin (Bioanalyse, Turkey) and nystatin (Sigma-Aldrich, USA) were used as reference substances. Inhibition zones were measured in millimeters at the end of an incubation period of 48 h at 28°C.
RESULTS AND DISCUSSION
Chemistry
A series of 6-aryl-5-cyano-2-thiouracils (1a-d) were newly synthesized in a facile manner from thiourea, ethyl cyanoacetate and different aldehydes in sodium ethoxide instead of anhydrous K 2 CO 3 /ethanol (14) (Table II) . The 1 H and 13 C NMR spectra of products 4a-d were compatible with the proposed structure. The IR spectra of compounds 5a-d showed the presence of C=O group; their 13 C NMR spectrum displayed signals for C=O carbon and for CH 2 aliphatic carbon. The rest of the spectrum was in good agreement with the structures. Compounds 6a-d and 7a-d were confirmed by spectral data (Table II) and the mass spectrum studies of these compounds gave additional evidence for the proposed structures. 1 H NMR for 8a-d showed singlet signals for COCH 3 and two NH, for 9a-d signals for CH 3, N-CH 3 and two NH, for 10a-d signals for two NH) and COOH. Also, MS spectra gave their molecular ion peaks (Table II) . The 13 C NMR spectra for compounds 8-10 were compatible with the proposed structures.
Antimicrobial activity
The data presented in Table III showed that compounds 2a-d and 7a-d possess a pronounced antimicrobial activity against Staphylococcus aureus, Bacillus subtilis and Escherichia coli compared to the reference drug penicillin. As far as antifungal activity is concerned, compounds 7a-d exhibited even stronger activity than nystatin against Candida albicans and compounds 2a, 2d, 3a, 7a and 7d against Aspergillus flavus. Compounds 1, 2 and 3a-d showed moderate activity against the fungus Candida albicans and compounds 4a and 6d displayed moderate activity against the fungus Aspergillus flavus. Compounds 9, 10a-d, 1, 3a-d, 4c, 5a,d and 6a,c were either inactive or moderately to fairly active against the tested bacteria. To sum up all tested compounds have moderate to high antibacterial activity, except compounds 9a-d and 10a-d, which are inactive. Compounds 2a,c and 7a showed the highest antibacterial activity whereas compounds 7a,d exhibited good to excellent results against Candida albicans and Aspergillus flavus. The present study revealed that conversion of cyano group at 5'-position to amide (2a-d) caused a pronounced inhibition effect against Gram-positive (Staphylococcus aureus, Bacillus subtilis) and Gram-negative (Escherichia coli) bacteria. The same effects were observed after transformation of Cl group into NHNH 2 (7a-d). On the other hand, increased antibacterial activity was achieved by incorporation of chloro moiety as in 4-chloro-6-(4-fluorophenyl)-2--thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (3a). However, cyclization to pyrimidoquinazolines, imidazopyrimidines, tetrapyrimidines, or incorporation of 4-aminoacetophenone as in 10-oxo-1-thioxo-3-(3,4,5-trimethoxyphenyl)-2,10-dihydro-1H-yrimido [6,1-b] Based on the above studies, the promising compounds can be submitted to in vivo antimicrobial studies as a future perspective.
